CASSANDRA HO: Open Payments
NPI 1124739271 · GOLDEN, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,789 in 72 payments from 16 companies in 2025. Trend: 2023 $1,823 · 2024 $2,132 · 2025 $1,789
Food & beverage: $1,590Education: $199
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $398 |
| ABBVIE INC. | 15 | $227 |
| Galderma Laboratories, L.P. | 7 | $225 |
| E.R. Squibb & Sons, L.L.C. | 7 | $187 |
| UCB, Inc. | 4 | $110 |
| PFIZER INC. | 5 | $107 |
| Novartis Pharmaceuticals Corporation | 4 | $96 |
| Regeneron Healthcare Solutions, Inc. | 3 | $88 |
| GENZYME CORPORATION | 3 | $84 |
| Organon LLC | 4 | $57 |
Products named: TREMFYA, NEMLUVIO, Sotyktu, DUPIXENT, SKYRIZI, Bimzelx, CIBINQO, RINVOQ.
Industry payments across CO — which companies pay providers there.
